Get the Stockscreener App
27.56
7.67%
-2.29
After Hours:
27.56
Anbio Biotechnology stock is traded at $27.56, with a volume of 22,592.
It is down -7.67% in the last 24 hours and down -36.17% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$29.85
Open:
$28.89
24h Volume:
22,592
Relative Volume:
0.25
Market Cap:
$1.21B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.27%
1M Performance:
-36.17%
6M Performance:
+338.16%
1Y Performance:
+0.00%
1-Day Range:
$27.35
$29.50
1-Week Range:
$27.35
$33.50
52-Week Range:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
27.56 | 1.31B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anbio Biotechnology Stock (NNNN) Latest News
Why Anbio Biotechnology’s Stock is Tumbling - TipRanks
Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 - digitalmore.co
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - inkl
Anbio Biotechnology Class A Shares Take a Tumble - TipRanks
White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday - Benzinga
Dow Jumps Over 200 Points; ISM Services PMI Falls In September - inkl
S&P 500 Futures Rise in Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - Barron's
Anbio Biotechnology Stock Tumbles Amid Volatility - TipRanks
Liverpool Ferry Port Faces Repairs Due to Berth Damage - Berawang News
Jake LaRavia Talks Lakers Role After JJ Redick’s Media Day Insights - Berawang News
Manchester United legend wants Arsenal to win the league – Daily Cannon - Berawang News
Will RSVR stock go up soonJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
What does recent volatility data suggest for GAN Limited2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
What the charts say about Deswell Industries Inc. todayTrade Volume Summary & Fast Moving Market Watchlists - Newser
Visual trend scoring systems applied to Puma Biotechnology Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is AMZE showing signs of accumulationEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
Sentiment Turns Positive on ASGN Incorporated — Reversal AheadWeekly Stock Report & Daily Momentum Trading Reports - beatles.ru
Is Climb Bio Inc. showing signs of accumulation2025 Trade Ideas & High Conviction Investment Ideas - Newser
Are Bears Losing Grip on BLFS? getLinesFromResByArray error: size == 0 - 더경남뉴스
Analyzing Share Issuance and Voting Rights Dynamics in Growth-Stage Biotechs: Navigating Governance and Dilution Risks - AInvest
What earnings revisions data tells us about iBio Inc.2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
LKY(linkey) Project ReviewTrade Exit Summary & Safe Entry Zone Identification - Newser
Is ACCESS Newswire Inc. forming a bottoming base2025 Year in Review & Expert Verified Movement Alerts - Newser
Real time breakdown of Graham Holdings Company stock performance2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Is ZVIA stock poised for growthDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Technical signs of recovery in Fortive Corporation2025 Big Picture & Technical Entry and Exit Alerts - Newser
How High Can FHE(mind network) Go2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Will Grayscale Ethereum Trust outperform the marketJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Live market analysis of HJJ CLMarket Movement Recap & Verified Technical Signals - Newser
Top Reasons to Buy PIX(pixelswap)July 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
What recovery options are there for RGC Resources Inc.Market Growth Review & Fast Exit and Entry Trade Guides - Newser
Arista Networks Volume Dives 27.46 to 97th Rank Amid Record Earnings and Analyst Upgrades - AInvest
Why Rapid7 Inc. stock attracts strong analyst attention2025 Sector Review & Risk Adjusted Buy/Sell Alerts - Newser
Is Greenland Technologies Holding Corporation’s ROE strong enoughRate Hike & Weekly High Conviction Trade Ideas - sundaytimes.kr
Should you hold or exit HONE nowLayoff News & Accurate Buy Signal Notifications - Newser
Can machine learning forecast TMUS recoveryEarnings Beat & Technical Buy Zone Confirmation - Newser
How do analysts view the current valuation of Nasdaq stocks? - AInvest
News impact scoring models applied to Cmb.Tech NVWall Street Watch & Daily Profit Focused Screening - Newser
How to read the order book for STRRPMarket Movers & Real-Time Chart Breakout Alerts - Newser
Leading vs lagging indicators on ETI.PR performanceFed Meeting & High Accuracy Swing Entry Alerts - Newser
The Unlocking of Voting Control in Anbio Biotechnology: A Post-Lock-Up Opportunity in a Dual-Class IPO - AInvest
Anbio Biotechnology's Post-Lock-Up Investment Implications: Unlocking Shareholder Value and Market Dynamics - AInvest
Anbio Biotechnology Class A Ordinary Shares Subject to Lock-Up Agreement Ending August 18, 2025. - AInvest
Certain Class B Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
Can MNTK expand its profit marginsMarket Trend Review & AI Forecasted Stock Moves - thegnnews.com
Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
Certain Class A Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
CompanyInsider Selling & Reliable Breakout Stock Forecasts - Newser
Zhengye Skyrocketed 33.84%—What’s Fueling This Biotech Breakout? - AInvest
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.84%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):